Fiche centre
Peking University People's Hospital
Beijing — China
Essais liés17clinical trials
VilleBeijinglocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07835152
Essais cliniques associés
17| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| MIL62 | Lupus | Phase 2 | NCT05796206 | A Phase 2 Clinical Study of MIL62 in Systemic Lupus Erythematosus | COMPLETED |
| S1904 CD19 CAR-T | SEP | Phase 2 | NCT07244406 | Assessment of Senl_B19 CAR-T Cells in Relapsed/Refractory CD19+ B-ALL | RECRUITING |
| Senl_B19 autologous CAR-T (S1904) treatment | SEP | Non applicable | NCT06581081 | Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic Leukemia | RECRUITING |
| Qishen Yiqi dripping pills 4 bags/time | Insuffisance cardiaque | Phase 2 | NCT04944706 | Efficacy and Safety of Qishenyiqi Dripping Pills for Treating Chronic Heart Failure With Preserved Ejection Fraction | COMPLETED |
| BMS-986504 | Cancer | Phase 2/3 | NCT07063745 | MountainTAP-29 — A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion | RECRUITING |
| Combined Cryoablation and Thermal Ablation system | Cancer | Non applicable | NCT07238894 | A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients | RECRUITING |
| BR005-036C | Migraine | Phase 3 | NCT07835152 | Long-term Safety of BR005-036C Tablets in the Acute Treatment of Migraine in Adults | NOT_YET_RECRUITING |
| SG301 SC Injection | Lupus | Phase 2 | NCT07447986 | To Evaluate the Efficacy and Safety of SG301 SC Injection in Systemic Lupus Erythematosus | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT05810038 | A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects. | COMPLETED |
| BR005-036C | Migraine | Phase 2/3 | NCT07792681 | Efficacy and Safety of BR005-036C Tablets for the Acute Treatment of Migraine in Adults | RECRUITING |
| ATG-201 | Lupus | Phase 1 | NCT07732309 | ATTRACT — A Study of ATG-201 in Adult Participants With Autoimmune Diseases | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06641466 | A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine | RECRUITING |
| Nipocalimab | Lupus | Phase 3 | NCT07438496 | GARDENIA-SLE — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus | RECRUITING |
| Budoprutug | Lupus | Phase 1/2 | NCT07564596 | A Phase 1b/2a Study of Budoprutug in Systemic Lupus Erythematosus (SLE) | RECRUITING |
| Cevostamab | Lupus | Phase 1 | NCT07629583 | To Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis | RECRUITING |
| Rimegepant | Migraine | Phase 3 | NCT06616194 | A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine | ACTIVE_NOT_RECRUITING |
| RJMty19 (CD19-CAR-DNT cells) | Lupus | Phase 1 | NCT06340490 | A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE) | NOT_YET_RECRUITING |